Completed NCT04786730
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including Little Rock ADHD Drug i A study involving a medication or substance. From 4 Years to 12 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Completed NCT04398225
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In Hollywood ADHD Drug From 4 Years to 12 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Completed NCT07253441
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including Lenexa ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Completed NCT03605836
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In Orlando ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Completed NCT00468143
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In New York ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor NYU Langone Health
Condition ADHD Completed NCT05417607
This study is completed in the United States. It focuses on ADHD.
In Durham ADHD Behavioral From 36 Months to 131 Months
Countries United States
Sponsor Duke University
Condition ADHD Completed NCT02911194
This study is completed. It focuses on ADHD and currently lists study information in the United Kingdom.
In Sunderland ADHD Other From 5 Years to 10 Years
Countries United Kingdom
Sponsor Northumbria University
Condition ADHD Completed NCT06311370
This study is completed in the United States. It focuses on ADHD.
In Brooklyn ADHD Other From 4 Years to 7 Years
Countries United States
Sponsor MaxisHealth
Condition ADHD Completed NCT01500694
This study is completed. It focuses on ADHD and currently lists study information in Austria, Belgium, France, Germany, Ireland, Italy, the Netherlands, Poland, Romania, Spain, Sweden, Ukraine, and the United Kingdom.
Multiple locations, including Graz ADHD Drug From 6 Years to 17 Years
Countries France, United Kingdom, Belgium, ...
Sponsor Shire
Condition ADHD Completed NCT04991649
This study is completed. It focuses on ADHD and currently lists study information in China.
In Tuenmen ADHD Behavioral From 3 Years to 12 Years
Countries China
Sponsor Chinese University of Hong Kong
Condition ADHD Completed NCT02562469
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In New York ADHD Other From 7 Years to 11 Years
Countries United States
Sponsor New York University
Condition ADHD Completed NCT05425966
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In San Francisco ADHD Behavioral Over 5 Years
Countries United States
Sponsor University of California, San Francisco
Condition ADHD